Antibiotic resistance: technical tricks against pathogens

Image: The photo shows the scanning of a blood sample in a laboratory at CiiM.; Copyright: Karin Kaiser / MHH

Karin Kaiser / MHH

What leads to severe COVID-19 diseases?

01/03/2023

Infection with SARS-CoV-2 leads to severe disease in some people, while others do not get ill or only experience mild disease. But why is this the case? Unfortunately, we do not know exactly. We do know that an overactive innate immune system is causing severe COVID-19 disease, but it is unclear how this is regulated.
Read more
Bild: DNA strand assembly from different elements. 3D illustration; Copyright: iLexx

iLexx

The architecture of shattered genomes

27/01/2023

Hunting for disease clues in the dark matter of our DNA. Scientists have reconstructed the chromosomes of patients with an extremely high number of aberrations in their genome that could alter the expression of nearby genes and potentially cause disease. Their results were published in Nature Communications in October 2022.
Read more
Image: Dr Anke Katharina Bergmann in a white coat, holding a tablet, is standing in front of a virtual map of Europe; Copyright: Karin Kaiser / MHH, Freepik.com

Karin Kaiser / MHH, Freepik.com

MHH leads EU large-scale project for personalized cancer care

26/01/2023

CAN.HEAL aims to expand the available innovations in cancer prevention, diagnosis and treatment in the Member States in order to improve care for all patients in the EU. The project focuses on measures of personalized medicine. Genomics is an important cornerstone for this.
Read more
Image: Researcher examines cell culture plates under the microscope; Copyright: manjurulhaque

manjurulhaque

Analyzing disease progression and cell processes with TIGER: in vivo and non-invasively

18/01/2023

Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have developed a technology they call TIGER. It allows complex processes in individual cells to be deciphered in vivo by recording past RNA transcripts.
Read more
Image: Two drops of water on a screen that shows a pattern of colored bars; Copyright: ktsimage

ktsimage

Big Data in genetics: reaching diagnosis through heaps of data

01/08/2022

Most laboratory tests only produce small amounts of data that are already sufficient for successful diagnosis. It becomes more difficult with genetic questions: whether it is about a genetic disease or the properties of tumors, there are large amounts of data that must be considered. Both research and medicine need help to identify the connections and patterns in the data to find a diagnosis.
Read more
Image: Two men are sitting in front of a laptop computer and are talking about an image on the screen - Josch Konstantin Pauling, Nikolai Köhler; Copytight: LipiTUM

LipiTUM

MoSBi: Algorithm identifies disease subtypes

01/08/2022

Doctors have always used symptoms, imaging, and laboratory data to define and diagnose diseases, but at times it is simply not enough: while patients may have the same illness, it may exhibit different changes at the molecular level. A team from the Technical University of Munich has developed the so-called MoSBi algorithm and makes it available to researchers to identify molecular differences.
Read more
Image: Gloved hand holds a cell culturing vessel in front of a screen with the depiction of a genetic analysis; Copyright: westend61

westend61

Big Data: Helper and game changer in laboratory medicine and genetics

01/08/2022

Big data, the use of large volumes of data in diagnostics and research, is giving medical science a powerful boost. Especially in laboratory medicine, big data can provide unprecedented support as doctors must consider a multitude of data and parameters to facilitate accurate medical decision-making.
Read more
Image: The Harmony COVID-19 test; Copyright: Mark Stone/University of Washington

Mark Stone/University of Washington

Fast and cheap test can detect COVID-19 virus' genome without need for PCR

25/01/2022

Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.
Read more
Image: Preview picture of video

LampSeq – Scalable and cost-effective mass test

15/10/2021

Vaccinations and tests once again enable safe gatherings during the Corona pandemic. But unfortunately, existing test technologies are not suitable for every situation: A lot of time is lost for example due to testing at schools and the workplace. Now the University Hospital Bonn has developed a new kind of test which has numerous advantages over existing technologies.
Read more
Image: Two men in white shirs - Kazuki Takahashi, Manabu Tokeshi; Copyright: Manabu Tokeshi

Manabu Tokeshi

SARS-CoV-2: rapid method to quantify antibodies

29/07/2021

Scientists have developed a rapid, highly accurate test to detect antibodies against the spike protein of SARS-CoV-2 in human serum, opening a new avenue for understanding the full extent of the pandemic and evaluating the effectiveness of vaccines.
Read more
Image: A swab is lying across a sample vial; Copyright: PantherMedia/fotoquique

Point-of-care tests: rapid diagnosis in emergency situations

01/06/2021

In emergency medicine, a faster diagnosis leads to a faster treatment of the patient. Point-of-care test solutions can provide immediate on-site insights into the patient’s condition. COVID-19 adds another dimension: the devices can provide a level of security and safety – one that goes beyond intensive care.
Read more
Image: A half-transparent red piece of tissue in a glass filled with a yellow fluid; Copyright: United Therapeutics

rhCollagen: genetically engineered building block for regenerative medicine

03/02/2020

Collagen is the stuff that holds our bodies together and that houses our cells. In regenerative medicine, it is also the stuff that can be applied to wounds to support healing. However, collagen from animal or human sources has some drawbacks for today’s medicine. This is where rhCollagen from the Israeli company CollPlant comes into play.
Read more
Image: A lab technician is using a pipette to fill a solution into a petri dish; Copyright: panthermedia.net/Arne Trautmann

Last-resort antibiotics: "We can identify carbapenemases within half an hour"

01/08/2019

Antibiotic resistance is modern medicine's greatest challenge. Some bacteria only respond to a handful of antibiotics, prompting hospitals to spend a lot of time finding an effective drug. That’s why it is critical for physicians to rapidly identify antibiotic resistance to avoid ineffective treatments.
Read more
Image: Preview picture of video

Multi-organ chips: Drug research without animal testing at vasQlab

15/05/2019

New active substances that are suitable for drugs are initially tested in animal experiments. However, the results cannot always be transferred to the human organism. At the Karlsruhe Institute of Technology, Prof. Ute Schepers from vasQlab explains how active substances can be tested in human tissue without endangering human health.
Read more